BME100 s2017:Group1 W8AM L1

BME 100 Spring 2017	Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help
OUR TEAM Name: Paulina Gomez Name: Arlette Geller Name: Emily Steeley Name: John Dell'Angelo Name: Hang Zheng Name: Shane Jones LAB 1 WRITE-UP Health Care Issue Malaria is the number one cause of death in many third world countries. Worldwide, it is the seventh leading cause of death. West Nile Virus, Zika, and Lyme’s disease are also very harmful and prevalent in some areas of the world. Malaria is transmitted from the female mosquito, after it bites, through its mouth. Customer Validation Harshavafhan Kalbhor; harshkalbhor11@gmail.com; India, resident Akshay Patil; akshaypatil1418@gmail.com; India, resident Alberto Moreno, MD; cameron@emory.edu/ 404-727-8611; Associate Professor at Emory Vaccine Center Dr. Stephen Agong; sgagong@bondo-uni.ac.ke; Kenya, President of Bondo University Dr. Carmen Rosa Mendez; carmen.mendez@essalud.gob.pe; Doctor of government institution at Peru Sudhakar Nhalade; sudhakar.nhalade@gmail.com; India Rotary Club President James Kublin; jkublin@fhcrc.org/ 206-667-1970; Clinical Research Professor, Global Health at the University of Washington Miguel Angel Ysaisa Barandiaran; miguel.bariandaran@essalud.gob.pe; Doctor of government institution at Peru Gururaj Joshi; gnjoshi@gmail.com; India Rotary Club Secretary Jorge Gabriel del Castillo Mory; gabriel.del.castillo@essalud.gob.pe; Doctor of government institution at Peru Manish Didmishe; +91 99300 04103; India Rotary Club Member Tabitha Sullivan, Ph.D.; (215) 432-5633; Professor of Childhood Development, traveler Peter Agre, M.D.; 443-287-8745; Principal Investigator for Malaria Transmission and the Impact of Control Effects in Southern Africa Edmundo Pablo Beteta Obreros; ebeteta@sis.gob.pe; Institutional chief of the Peruvian ministry of health Liwang Cui, Ph.D.; luc2@psu.edu; Principal Investigator at the Southeast Asia Malaria Research Center Geoffrey McFadden; gim@unimelb.edu.au; Malaria researcher in the University of Melbourne Patricia Jannet Garcia Funegra; +511 28072808; Peruvian health minister Matthew Dorsey, M.D.; gdorsey@medsfgh.ucsf.edu; Principal Investigator in the Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda James Kazura, M.D.; jxk14@case.edu/ 216-368-4810; Principal Investigator for Research to Control and Eliminate Malaria in SE Asia and SW Pacific Donald Krogstad, M.D.; krogstad@tulane.edu/ 504-988-6618; Principal Investigator for Population-based Approach to Malaria Research and Control in West Africa Competitors Advantages There aren’t direct competitors. Our indirect competitors are companies such as Bugaway Brands LLC, DAIHO PARFUMERY Co Ltd, REFRE Co Ltd, Suzuki Yuhi Industries Co Ltd, Bioniche Life Sciences Inc, Feil, and Advanced Medical Instruments. These products are effective in deterring mosquitos, along with other malarial spreading pests. They are capable of lasting for an extended amount of time. Disadvantages Current competitors are merely used in order to deter pests. There are no technologies, as of now, that work to inhibit the transmission of malarial diseases. IP Position There are existing patents for regular bug spray repellent, but none for a spray/lotion that works to clog mosquitos’ saliva to prevent the disease from entering a human system. Bug spray does not require FDA approval, but it does need EPA approval, unless its active ingredient is among a number of unregistered oils. Existing patents are: Bugaway Brands LLC (US7201926B2) DAIHO PARFUMERY Co Ltd; REFRE Co Ltd; Suzuki Yuhi Industries Co Ltd (US20060257441A1) Feil (DE1997129852) Bioniche Life Sciences Inc (US7381431B2) Advanced Medical Instruments (US09192421) Taiko Pharmaceutical Co. Ltd., School corporation Jichi Medical University (CN 200980118927) Fundability Worksheet Scores Competitors 2 Customer Validation 2 IP Position 2